Drug updated on 11/4/2024
Dosage Form | Emulsion (topical: 0.5 mg/mL) |
Drug Class | Calcineurin inhibitor immunosuppressants |
Ongoing and Completed Studies | ClinicalTrials.gov |
Indication
- Indicated to increase tear production in patients whose tear production is presumed to be suppressed due to ocular inflammation associated with keratoconjunctivitis sicca.
Latest News
Summary
- This summary is based on the review of two systematic review(s)/meta-analysis(es). [1-2]
- Ocular Rosacea Treatments: Topical antimicrobials achieved a complete or partial response in 91% (n = 82/90) of patients, while oral antibiotics reached 89% (n = 525/580), and cyclosporine ophthalmic emulsion demonstrated an 87% response rate (n = 40/46). Combination treatments were also effective, yielding a response rate of 90% (n = 69/77).
- Dry Eye Disease Treatments: Restasis (cyclosporine ophthalmic emulsion) showed the highest efficacy for reducing Ocular Surface Disease Index (OSDI) scores, with an odds ratio of 4.82 (95% CI 6.18 to 3.45). Zirun outperformed others in improving Schirmer's test scores (SUCRA (surface under the cumulative ranking curve) 73.9%), while TJ Cyporin was ranked highest for improving tear film break-up time (SUCRA 65.3%).
- There is no safety information available in the reviewed studies for cyclosporine ophthalmic emulsion or other treatments for ocular rosacea. For dry eye disease, Clacier had the lowest incidence of treatment-emergent adverse events, comparable to placebo, while no specific safety outcomes were mentioned for Restasis.
- There is no population types or subgroups information available in the reviewed studies.
Product Monograph / Prescribing Information
Document Title | Year | Source |
---|---|---|
Restasis (cyclosporine ophthalmic emulsion) Prescribing Information. | 2024 | AbbVie Inc., North Chicago, IL |
Systematic Reviews / Meta-Analyses
Document Title | Year | Source |
---|---|---|
Treatment of ocular rosacea: a systematic review | 2024 | Journal Der Deutschen Dermatologischen Gesellschaft = Journal Of The German |
Comparison of seven cyclosporine A formulations for dry eye disease: A systematic review and network meta-analysis | 2022 | Frontiers In Pharmacology |
Clinical Practice Guidelines
Document Title | Year | Source |
---|---|---|
Perceptions of dry eye disease management in current clinical practice. | 2014 | Eye and Contact Lens |